C. Ruegg

Discipline

Histoire, Philosophie et Sociologie des sciences (2) Psychologie (1)

Type de document

Articles (20) Recensions (3) Colloques et conférences (2)

Co-auteur

Date

Source

Mot-clé

Cells (17) Cancer (15) cancer (14) Cancer (14) Treatment (13) Human beings (13) Neovascularization (12) thérapie (11) Therapeutics (11) Mice (9) Growth (9) Blood (9) Growth (9) spectacle (7) survie (7) Survival (7) Patients (7) Expression (7) Cancer cells (7) Breast (7) Animals (7) Use (7) Patients (7) Tumors (6) Inhibition (6) Evidence (6) Endothelial cells (6) protéine (5) modèle (5) ligne (5)

Documents écrit par C. Ruegg (22) | parle de C. Ruegg (0)

Targeting OLFML3 in Colorectal Cancer Suppresses Tumor Growth and Angiogenesis, and Increases the Efficacy of Anti-PD1 Based Immunotherapy.
J. Stalin et al. (15 sept. 2021)
Dormant Tumor Cell Vaccination: A Mathematical Model of Immunological Dormancy in Triple-Negative Breast Cancer.
R. Mehdizadeh et al. (11 janv. 2021)
Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer.
Q. Lan et al.
Consensus guidelines for the use and interpretation of angiogenesis assays.
P. Nowak-Sliwinska et al.
Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients.
S. Cattin et al. (8 mars 2016)
Discovery of a 29-gene panel in peripheral blood mononuclear cells for the detection of colorectal cancer and adenomas using high throughput real-time PCR.
L. Ciarloni et al. (2015)
Fibroblast surface-associated FGF-2 promotes contact-dependent colorectal cancer cell migration and invasion through FGFR-SRC signaling and integrin αvβ5-mediated adhesion.
S. Knuchel et al. (2015)
Angiogenic activity of breast cancer patients' monocytes reverted by combined use of systems modeling and experimental approaches.
N. Guex et al. (2015)
Inhibition of cell migration and invasion mediated by the TAT-RasGAP317-326 peptide requires the DLC1 tumor suppressor.
D. Barras et al. (2014)
Fragment N2, a caspase-3-generated RasGAP fragment, inhibits breast cancer metastatic progression
D. Barras et al. (2014)
Identification of MAGI1 as a tumor-suppressor protein induced by cyclooxygenase-2 inhibitors in colorectal cancer cells.
J. Zaric et al. (2012)
Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARα mediated mechanism.
S. Garrido-Urbani et al. (2011)
Tenascin-W is a specific marker of glioma-associated blood vessels and stimulates angiogenesis in vitro.
E. Martina et al.
Targeting integrins in malignant glioma.
G. Tabatabai et al. (2010)
Radiotherapy suppresses angiogenesis in mice through TGF-betaRI/ALK5-dependent inhibition of endothelial cell sprouting.
N. Imaizumi et al. (2010)
MMP-9 as predictive factor for response and progression free survival in breast cancer patients treated with bevacizumab and pegylated liposomal doxorubicin. A multicenter, single-arm phase II trial (SAKK24/06). On behalf of the Swiss Group for Clinical Cancer Research (SAKK).
K. Zaman et al. (2010)
hMMP9 as predictive factor for response and progression free survival in breast cancer patients treated with bevacizumab and pegylated liposomal doxorubicin (PLD)
K. Zaman et al. (2010)
Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia.
A. Murat et al. (2009)
Thalidomide in small cell lung cancer: wrong drug or wrong disease?
C. Rüegg et al. (2009)
Myeloid cells contribute to tumor lymphangiogenesis.
A. Zumsteg et al. (2009)
The tumor microenvironment and its contribution to tumor evolution toward metastasis.
G. Lorusso et al. (2008)
The chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumour and metastatic growth, but not invasion.
R. Meier et al. (2007)